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Early data on glomerular physiology and pathophysiology
were largely based on morphological studies and on functional
studies of either glomeruli in vivo or isolated glomeruli. The
introduction of glomerular cell culture in the late seventies and
early eighties has allowed a more specific approach to the role
of individual glomerular cell types in the mediation of renal
pathology [1—3]. Over the last five years there has been a
tremendous increase in studies dealing with cultured glomerular
cells. For example, the number of abstracts on mesangial cells
in culture that have been presented at the annual meeting of the
American Society of Nephrology has increased from about 10 in
1988 to about 150 in 1992. In contrast, only about 25 studies
dealt with glomerular epithelial cells last year, and very few
with glomerular endothelial cells, which is likely a reflection of
the ease at which these cells can be grown out of isolated
glomeruli. As discussed in several recent papers, these in vitro
studies have shown that glomerular cells have a wide range of
synthetic activities and response patterns [this issue of Kidney
International, 1—8].
Based on the in vitro characterization of the capabilities of
glomerular cells, physiological or pathological pathways have
been suggested that may be operative in vivo. However, when
working with cells isolated from glomeruli and when attempting
to extrapolate to the in vivo situation, several issues need to be
addressed. First, what type of cells has been obtained and how
do their morphological characteristics compare to those ob-
served in vivo? Second, is there evidence to suggest that
cultured cells exhibit the same synthetic profile as they do in
vivo or do they synthesize products that can not be detected in
vivo under normal or pathological circumstances? Third, are the
responses of cultured glomerular cells comparable to those
observed in vivo or do they show response patterns that are
restricted to the petri dish?
In the following review we will discuss these three issues by
way of example rather than by attempting to give a complete
overview. Finally, we will restrict our discussion to glomerular
mesangial and epithelial cells, since too little information is
available on glomerular endothelial cells either in culture or in
vivo.
Cells in culture, but which ones?
Glomerular cells have been derived from either intact, iso-
lated glomeruli (epithelial cells) or collagenase digested isolated
© 1994 by the International Society of Nephrology
glomeruli (mesangial cells). For this, glomeruli are placed into
tissue culture medium, containing high concentrations of nutri-
ents and growth factors, and are then regularly checked for
cellular outgrowths [1—3]. Until recently (see below) such
cultures were performed in two dimensional culture on either
uncoated petridishes (mesangial cells) or petridishes that were
pretreated with various attachment factors, usually some extra-
cellular matrix protein (epithelial cells) [1—3]. The isolation of
individual glomerular cell types from these primary outgrowths
was then achieved by either cloning methods (rarely, since not
very efficient) or, more frequently, by repeated subculture
under conditions that select for one of the cell types [1—3]. Cells
are then characterized using morphological, immunohistologi-
cal and functional criteria [1—3].
The approach described above has some specific inherent
problems that may complicate the isolation of individual cell
types. First, the preparation of glomeruli from whole kidney or
renal cortex almost never yields an absolutely pure population
of glomeruli, but is usually contaminated to low degrees with
tubular and presumably interstitial tissue. Second, although
most glomeruli lose their capsule during the isolation proce-
dure, Bowman's capsule, various lengths of the proximal tu-
bule, and/or the vascular pole may still be attached to some
isolated glomeruli. Although morphologic, immunohistochemi-
cal, and functional methods may distinguish many of the cell
types from each other, this is not the case in other instances.
For example, it may be difficult to exclude the possibility that
mesangial cell preparations are contaminated by either intersti-
tial fibroblasts or smooth muscle cells, both of which show a
number of features reminiscent of mesangial cells [4, 6, 9], or to
differentiate whether a preparation of glomerular epithelial cells
contains predominantly visceral or parietal glomerular epithe-
hal cells [10—12].
Other caveats originate from the cell culture conditions
themselves. As outlined by Lovett and Sterzel in 1986 [3],
glomerular cell characteristics will depend on species, age of
donor, and the degree of confluency of the cells. Also, the
matrix, no matter whether synthesized by the cells themselves
or provided in the petri dish, may exert marked influences on
the morphology and behavior of the cultured cells [13, 14].
Another, very important variable is the time that a cell has been
in culture. Thus, with increasing numbers of passages the risk
of selecting subpopulations or even contaminating cell types is
likely to increase and chromosomal alterations become very
frequent [15] (Fig. 1). This latter point is of particular concern
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Fig. 1. Comparison of the normal
chromosomal set of rats (Rattus norvegicus)
(small insert boxes) with a representative
karyolype of cultured Sprague-Dawley rat
mesangial cells that could be maintained in
culture for more than 20 passages. The
karyogram of the cells after prolonged culture
shows several structural and numerical
aberrations (grey oval circles): One
chromosome 4 is replaced by a Robertsonian
translocation t(4;4), one of chromosomes
number 6 and 7 has additional parts attached
to the long arms, there is a third chromosome
13, one chromosome 15 is deleted, one
chromosome 20 shows a partial deletion, and
finally two marker chromosomes (non-
classifiable chromosomes) are present.
when immortalized glomerular cells, for example virus-trans-
formed cells, are investigated. With most glomerular cells in
culture, however, a high number of passages is not possible
since they will spontaneously cease to proliferate after a certain
time in culture. If this is not the case, either a dedifferentiation
or a spontaneous virus-transformation must be assumed. A last
caveat is derived from the repeated usage of non-autologous
serum to propagate cells, which contains not only platelet
release products and products of the coagulation pathway but
frequently considerable amounts of endotoxin. Thus, it is clear
from this discussion that the interpretation and particularly the
comparison of cell culture data should only be attempted after
a thorough analysis of the conditions under which the cells were
obtained.
Synthetic activities in culture and in vivo
As outlined in the previous articles, both glomerular mesan-
gial and epithelial cells in culture are metabolically active cells.
Major classes of synthesized products include inflammatory
mediators, structural proteins, such as elements of the cytoskel-
eton, and extracellular matrix proteins. In the following we will
compare the synthesis of selected proteins out of these three
classes in vitro with that observed under normal or pathological
conditions in vivo.
Mesangial cells
Inflammatory mediators
As an example, we will analyze the synthesis of platelet-
derived growth factor (PDGF) in vitro and in vivo. PDGF is a
mediator that, among other biological actions, is involved in
organogenesis, wound healing, and the pathogenesis of athero-
sclerosis, fibrotic diseases and inflammatory joint disease 116].
In cultured mesangial cells, PDGF synthesis can be demon-
strated [17] and PDGF exhibits mitogenic (see below) [18] and
chemotactic [19] activities for these cells. It is also involved to
some extent in the regulation of their matrix synthesis [20] as
well as the synthesis of other mediators, such as prostaglandins
[21]. In vivo PDGF B-chain mRNA and protein can be demon-
strated in low to moderate amounts in the normal glomerulus,
where it localizes by in situ hybridization and immunostaining,
respectively, to mesangial regions [22—251. In diseases that are
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Table 1. Comparison of selected synthetic activities of glomerular
mesangial cells in in vitro, under normal in vivo conditions, and
during glomerular disease in vivo
In vitro
In vivo
normal Pathol.
Mediators
PDGF B-chain ++ [17] + [22—25] ++ [22—27]
Structural proteins
a-Smooth muscle + + [281 — [29](Rat) + ÷ [27, 29—31]
act in
Desmin ++ [32] + [29, 33—36) ++ [29, 35, 36]
Matrix proteins
Type I collagen ++ [45] — [41-44] ++ [41—43, 46, 47]
Type IV collagen + [45] + [37—40, 42, 433 + + [37—40, 42, 43]
Signs signify: —, absent; +, weak to moderate; and ++, strong
expression. Numbers in brackets refer to the corresponding references.
characterized by enhanced mesangial cell proliferation, up-
regulated synthesis of glomerular PDGF B-chain can be dem-
onstrated [22—27]. Thus, in the case of PDGF there is high
consistency of in vitro and in vivo observations (Table 1).
Structural proteins
As shown in Table 1 and Figure 2, expression of a-smooth
muscle actin can be readily demonstrated as part of the cy-
toskeleton of cultured rat mesangial cells [28]. In the normal rat
kidney, however, a-smooth muscle actin is not present within
the glomerulus (Fig. 2) [29]. An apparent de novo expression of
a-smooth muscle actin in the mesangium in vivo only occurs in
instances of severely altered glomerular hemodynamics, in
which the mesangial cell is exposed to increased stretch:
selective disruption of the mesangial architecture following
administration of an anti-mesangial cell antibody (anti-Thy 1.1;
Fig. 2) [29], increased glomerular capillary pressure following
5/6 nephrectomy [27] or infusion of angiotensin II [30], or
hyperfiltration in diabetic nephropathy [311 (Table 1). In con-
trast to a-smooth muscle actin, other cytoskeletal elements of
the mesangial cell, such as desmin, show a more consistent
expression (Fig. 3). Thus, desmin can be demonstrated in vitro
as well as in the normal mesangium in vivo and finally, in
increased amounts, in the pathologically altered mesangium
[29, 32—36] (Table 1).
Extracellular matrix proteins
Table 1 shows that, in contrast to type IV collagen, the
normal glomerular extracellular matrix by immunostaining is
devoid of interstitial types of collagen (types I and III) [37—43].
It has also been impossible to demonstrate any type I collagen
mRNA in normal glomeruli even when using isolated single
glomeruli and the polymerase chain reaction [44]. On the other
hand, in vitro 95% of the collagen synthesized by mesangial
cells consists of the interstitial collagen types land III, and only
very low amounts of type IV collagen are produced [45]. Under
pathological conditions in vivo the glomerular content of type
IV collagen increases [37—40, 42, 43] but the appearance of
interstitial collagens in the glomerulus has also been repeatedly
shown [41—43, 46, 47]. However, it has been argued that these
latter collagens were derived from interstitial fibroblasts invad-
ing the glomerular tuft following the disruption of Bowman's
capsule [47]. It was therefore of great interest to us to observe
the ubiquitous glomerular expression of type I collagen in the
anti-Thy 1.1 mesangioproliferative glomerulonephritis model in
the rat [42], since in this model the injury is directed against the
niesangial cells and since the disease is not characterized by
breaks in Bowman's capsule [29]. This suggested that intrinsic
glomerular cells, most likely the niesangial cells, were respon-
sible for the overproduction of type I collagen in this nephritis
model [42]. Thus, this model provides an in vivo correlate for
the predominant interstitial type collagen production by cul-
tured mesangial cells (Table 1).
Glomerular epithelial cells
Inflammatory mediators
We have recently obtained evidence showing that nonstimu-
lated glomerular epithelial cells in culture, similar to mesangial
cells, synthesize low amounts of PDGF B-chain [48]. In vivo,
neither PDGF B-chain protein nor mRNA could be demon-
strated in visceral or parietal epithelial cells of normal rat
kidney by immunohistology and in situ hybridization, respec-
tively [22—27]. However, following the induction of an experi-
mental membranous nephropathy (passive Heymann nephritis),
both visceral and parietal glomerular epithelial cells transiently
expressed PDGF B-chain protein and mRNA [48] (Table 2).
Structural proteins
Glomerular epithelial cells in culture, like mesangial cells, are
characterized by their cytoplasmic expression of vimentin, a
common element of the cytoskeleton [49, 50]. Unlike mesangial
cells however, they do not express desmin [51]. In vivo, the
expression of vimentin in normal glomeruli is strong in visceral
and weaker in parietal epithelial cells [33—36], while desinin may
be detected in low amounts in some visceral but not in parietal
epithelial cells [29, 33—36]. In contrast to vimentin, where no
marked changes of the glomerular epithelial staining pattern
have been observed in disease models involving the glomerular
epithelial cells [35, 36], marked increases in the expression of
desmin by visceral but not parietal epithelial cells can be noted
when stretch is imposed on the glomerulus in vivo [35, 36]
(Table 2). This discrepancy of the in vitro and in vivo findings in
the case of visceral epithelial cells but not in parietal epithelial
cells (Table 2) supports the notion that most glomerular epithe-
hal cells in culture may in fact be of parietal rather than visceral
origin [10—12].
Extracellular matrix proteins
Very similar to the mesangial cell, some type I collagen can
be demonstrated in cultured glomerular epithehial cells [2, 51],
while the normal glomerulus is devoid of this collagen type (see
above). In experimental membranous nephropathy, however,
type I collagen mRNA increases in the glomeruli [52] and by in
situ hybridization this increase has been localized to visceral
epithelial cells [53]. An apparent de novo expression of type I
collagen protein in visceral epithelial cells has also been noted
in this disease model [52]. Furthermore, expression of type I
collagen in the cytoplasm of visceral as well as parietal epithe-
hal cells was observed following 5/6-nephrectomy in rats [43].
Thus, similar to PDGF B-chain, the expression of type I
collagen by glomerular epithelial cells represents an example, in
-'C-
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Fig. 2. Expression of a-smooth muscle actin by cultured rat mesangial
cells (A), in normal rat glomeruli (B), and following the induction of
an experimental mesangioproliferative glomerulonephritis (C) in rats.
While there is positive staining of cultured mesangial cells, no a-smooth
muscle actin can be detected in normal glomeruli. An apparent de novo
expression, however, occurs following the induction of glomerulone-
phritis.
which the phenotype of the cultured cells resembles that of an
injured cell in vivo rather than that of a normal cell in vivo.
Cellular responses in the petri dish and in the glomerulus
Mesangial cells
A major pathological response pattern of mesangial cells to
injury in vivo is an increase in their proliferation rate. Aug-
mented mesangial cell proliferation has been documented in a
multitude of glomerular diseases, ranging from various glomer-
ulonephritides, diabetic nephropathy to the changes following
extensive loss of renal mass [27, 54—56]. Cell culture has
provided an excellent opportunity to investigate the nature of
the factors involved in this abnormal proliferative response.
Indeed, a large number of factors with mitogenic activity for
mesangial cells, some with growth inhibitory capabilities and
some with no effect have been identified in such experiments
[reviewed in 4, 5, 55, 57]. In contrast, however, there is
relatively little information on the factors regulating mesangial
cell proliferation in vivo.
In the normal glomerulus in vivo there is little cell turnover
and 70 to 80% of the proliferating cells are identified as
endothelial cells, while mesangial cells only account for 10 to
20% [58]. This observation is in relative contrast to data
obtained in cell culture, which show that mesangial cells, at
least in their early passages, are highly proliferative and that
even the complete withdrawal of serum and protein from the
cell culture medium can not induce a complete growth arrest of
these cells [211. In this respect cultured mesangial cells are
more similar to the activated mesangial cell in vivo, since, as
noted above, mesangial cell proliferation is a common occur-
rence in a variety of glomerular diseases (Table 3).
One of the most thoroughly investigated mesangial cell mito-
gens is PDGF and in particular the B-chain of PDGF. Thus,
mesangial cells in culture exhibit a strong proliferative response
when stimulated with PDGF [18, 59], and the intrinsically
produced PDGF may act as an autocrine growth factor [18].
This latter observation potentially explains why it is not possi-
ble to completely growth arrest mesangial cells in culture. As
noted above, in vivo PDGF B-chain mRNA and/or protein are
expressed in low amounts in normal glomeruli and are overex-
pressed in mesangioproliferative states. A neutralizing antibody
to PDGF was able to reduce the pathological mesangial cell
proliferation observed in the anti-Thy 1.1 nephritis [60], and,
vice versa, infusion of recombinant PDGF into normal rats
induced selective mesangial cell proliferation in vivo [61]. Thus,
the mesangial cell response to PDGF is another example of
consistency of cell culture findings and in vivo observations
(Table 3).
Similar to PDGF, basic fibroblast growth factor (bFGF) is
also a potent mesangial cell mitogen in culture [18] and, again,
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Fig. 3. Expression of desmin by cultured rat mesangial cells (A), in
normal rat glomeruli (B), and following the induction of an
experimental mesangioproljferative glomerulonephritis (C) in rats.
Desmin is consistently detected in vitro, in the normal in vivo
situation and, in increased amounts, in the hypercellular mesangium
following the induction of nephritis.
Table 2. Comparison of selected synthetic activities of visceral ("v")
and parietal ("p") glomerular epithelial cells in in vitro, under normal
in vivo conditions, and during glomerular disease in vivo
vitro
in vivo
In Normal Pathol.
Mediators
PDGF B-chain + [48] v — [22—25]
p — [22—25]
v ++ [48]
p ++ [48]
Structural proteins
Vimentin ++ [49, 50] v ++ [33—36]
p + [33, 34, 36]
v ++ [35, 36]
p + [35, 36]
Desmin — [51] v [29, 33—36]
p — [29, 33—36]
v ++ [35, 361
p — [35, 36]
Matrix proteins
Type I collagen + [2, 51] v — [41—44]
p — [41—43]
v + [43, 52, 53]
p + [43]
Signs signify: —, absent; +, weak to moderate; and ++, strong
expression. Numbers in brackets refer to the corresponding references.
bFGF is produced by both mesangial cells in culture and
mesangial cells in vivo [62]. However, in contrast to cell
culture, neither bolus injections nor a one week infusion of
recombinant bFGF into nonnal rats elicited a mesangioprolif-
erative response [61, 62]. Only after the mesangial cells in vivo
had suffered a minor injury (injection of a low dose of an
anti-mesangial cell antibody), was a moderate proliferation of
Table 3. Comparison of selected cellular responses of glomerular
mesangial cells in in vitro, under normal in vivo conditions, and
during glomerular disease in vivo
In vitro
In vivo
Normal Pathol.
Proliferation
No additional stimulus + [1—3] + [58] ++ [54—56]
Proliferation following
administration of:
PDGF ++ [18, 59] ++ [61] ++ [611
bFGF ++ [18] — [61, 621 + [61, 62]
Angiotensin II [64—67] — [30, 68] — [unpubi.]
Signs indicate: —, absent; +, weak to moderate; and ++, strong
response. In the case of PDGF, bFGF and angiotensin II only the
increase above basal conditions (no additional stimulus) is depicted.
Numbers in brackets refer to the corresponding references.
mesangial cells observed in response to the administration of
bFGF [61, 621. Thus, in contrast to PDGF, the cellular respon-
siveness of mesangial cells towards bFGF depends on their
status in vivo and cultured mesangial cells behave similar to
injured but not to normal mesangial cells in vivo (Table 3).
A third growth factor that has received increased attention
over the last years is angiotensin II. In vascular smooth muscle
cells, which in many ways resemble mesangial cells [4, 6],
angiotensin II does not exert mitogenic effects but rather
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Table 4. Comparison of selected cellular responses of visceral ("v")
or parietal ("p") glomerular epithelial cells in in vitro, under normal
in vivo conditions, and during glomerular disease in vivo
n vitro
in vivo
I Normal Pathol.
Proliferation
No additional stimulus + [10—12] v —
p +
[58]
[58]
v +
p ++
[48]
[69, 70]
Proliferation following
administration of:
PDGF — [48] v —
p—
[61]
[61]
v —
p—
[61]
(61]
bFGF + [73] v —
p—
(61, 62]
[61,62]
v
p?
Signs indicate: —, absent; +, weak to moderate; and ++, strong
response. In the case of PDGF and bFGF only the increase above basal
conditions (no additional stimulus) is depicted. Numbers in brackets
refer to the corresponding references.
induces cellular hypertrophy [63]. Similarly, in cultured human
mesangial cells derived from adult angiotensin II is not mito-
genie [64, 65]. Reports by other authors of low grade mitogenic
effects of angiotensin II may relate to the usage of fetal or
immortalized mesangial cells [66, 67]. In vivo there was only a
marginal increase in the glomerular cell proliferation rates in
normal rats [30] and none in rats with a mesangioproliferative
nephritis [R. Johnson, unpublished data] infused for up to two
weeks with angiotensin II. More importantly, in one-clip,
two-kidneys Goldblatt rats at 11 weeks after disease induction
there was no effect on glomerular cell proliferation or cell
counts in the clipped kidneys, which are exposed to high levels
of angiotensin II but not to hypertension [68]. This cellular
response towards angiotensin II therefore exemplifies that
low-grade effects in vitro may not be demonstrable in vivo
(Table 3), and the biological relevance of such cell culture
lindings has to be questioned.
Glomerular epithelial cells
If increased proliferation of glomerular epithelial cells is
evaluated again as a response pattern, there is evidence that
parietal epithelial cells can proliferate in vitro [10—12] as well as
under normal and pathological conditions in vivo [58, 69, 70]. In
the case of the visceral epithelial cells, however, it has been
hypothesized that these cells are terminally differentiated in
vivo and are therefore incapable of exhibiting any proliferative
response [71]. Indeed in normal rat glomeruli, no proliferation
of visceral epithelial cells has been detected [58]. We have,
however, demonstrated recently that in an experimental model
of membranous nephropathy (passive Heymann nephritis), in
which cytotoxic injury is directed against the visceral epithelial
cells, some regenerative response, that is, proliferation, of the
visceral epithelial cells occurs [481. The in vitro correlate of this
observation is provided by the mere fact that it is possible to, at
least temporarily, induce an outgrowth of not only parietal but
also visceral epithelial cells from isolated glomeruli [10—12]
(Table 4).
An example of consistently negative responses of glomerular
epithelial cells is their response towards PDGF. Thus, both in
vitro and following a one week infusion of recombinant PDGF
in vivo, there was no detectable proliferation of visceral epithe-
hal cells, nor an increase in the proliferation of parietal epithe-
hal cells in the rat [61] (Table 4). In agreement with this, no
expression of PDGF receptor /3-subunit, the receptor for the
PDGF B-chain, could be demonstrated on visceral or parietal
epithehial cells in vivo in the rat [22, 27]. An exception may be
in human and primate kidneys, where the PDGF receptor
/3-subunit is present on parietal but, again, not on visceral
glomerular epithelial cells [72].
Basic FGF has recently been shown to be mitogenic for
glomerular epithelial cells in culture [73]. In contrast, when
recombinant bFGF was injected or infused into normal rats
there was no increase of glomerular epithelial cell proliferation
[61]. However, to date it has not been determined whether
previous injury of these cells, analogous to the experiments
with mesangial cells (see above), renders them susceptible to a
mitogenic effect of bFGF in vivo (Table 4).
Conclusions
Although marked progress has been made in the last 15 years
in establishing glomerular cells in culture and in characterizing
them, certain problems still have not been resolved. While
glomerular cells are cultured under relatively similar conditions
in many laboratories, no definitive consensus on optimal culture
conditions exists, and this diversity as well as potential species
differences have to be kept in mind when interpreting and, in
particular, when comparing results that have been obtained
with such cells. In the light of these caveats, it is not surprising
that in some cases divergent results have been obtained, such as
in the case of tumor necrosis factor synthesis by mesangial cells
[74, 75] or their proliferative response after stimulation with
interleukin 1 [59, 76—78] or interleukin 6 [59, 79, 80]. On the
other hand, in particular when strong biological effects were
observed, for example the mitogenicity of PDGF B-chain for
mesangial cells, results between different laboratories show
remarkable consistency.
In the previous sections we have outlined that not only cell
culture data among themselves, but results obtained in vitro
and in vivo may also yield both highly consistent as well as
divergent data. However, in the cases where cell culture
findings and findings in normal renal tissue differed, it has so far
been possible in all instances to detect the respective in vivo
correlate in disease states. Taken together the data currently
available therefore suggest that under standard culture condi-
tions glomerular cells in vitro exhibit the phenotype of a
pathologically activated cell in vivo. The data also suggest that
glomerular cell culture, at least when performed with non-
immortalized cells, is not that unphysiological that it induces a
complete dedifferentiation of the cells, since so far there are no
examples of synthetic activities or response patterns in vitro
that do not have any in vivo correlates.
Will glomerular cell culture eliminate the need for in vivo
studies?
Glomerular cell culture has provided enormous insights into
the capabilities of individual cell types. It has provided direct
evidence for synthetic activities that can only, if at all, be
inferred indirectly from observations in vivo, such as the
production of extremely shortlived compounds including oxy-
gen radicals or leucotrienes by glomerular cells [1—6, 81—83].
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Certainly, the single most important role of glomerular cell
culture resides in this qualitative description of the synthetic
capabilities of these cells. However, while yielding a wealth of
data, current cell culture has not allowed us to judge the relative
importance of synthetic capabilities or response patterns in
glomerular physiology and pathology. A good example of this is
the synthesis of erythropoietin by mesangial cells in culture
[841, which, however, in vivo is quite irrelevant compared to the
renal interstitial production of erythropoietin [85]. Also, in
cases where glomerular cells simultaneously produce mediators
with antagonizing biological effects, for example vasodilatory
prostaglandins and vasocontrictive endothelin [4—6, 21, 86], cell
culture will hardly be able to provide clues to the in vivo net
effect. Thus, at this point in time we believe that the clinical or
physiological relevance of individual cell culture findings re-
quires verification in vivo.
In an attempt to closer approach the in vivo situation many
investigators have begun to extend or modify the "standard"
cell culture techniques for glomerular cells, for example by
investigating the effects of parallel stimulation with more than
one mediator [59, 82, 87], by investigating the cells in serum-
free culture [21, 59], by exposing them to stretch [88], by
co-culturing different glomerular or glomerular and inflamma-
tory cell types [89, 90], or by seeding the cells into a three-
dimensional matrix [9 1—93]. On the other hand these studies too
can only shed light on single aspects and furthermore are likely
to introduce yet other specific problems inherent to these new
techniques, such as the choice of the matrix when investigating
cells in three-dimensional culture [91, 92]. Thus, only time will
tell whether these newer techniques will provide further an-
swers or yet more questions, and whether they at some point
have the potential to eliminate the need for in vivo experiments.
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